Avita Medical
RCEL
34 hedge funds and large institutions have $43.1M invested in Avita Medical in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 12 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
19% more capital invested
Capital invested by funds: $36.4M → $43.1M (+$6.78M)
0.01% more ownership
Funds ownership: 0.05% → 0.07% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 36 → 34 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
53% less call options, than puts
Call options by funds: $427K | Put options by funds: $910K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$7.25M |
| 2 |
Renaissance Technologies
New York
|
+$2.06M |
| 3 |
JP Morgan Chase
New York
|
+$904K |
| 4 |
Jane Street
New York
|
+$442K |
| 5 |
MA
MCF Advisors
Covington,
Kentucky
|
+$369K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Blackcrane Capital
Bellevue,
Washington
|
-$3.41M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$240K |
| 3 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$197K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$147K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$123K |
RCEL Hedge Fund Activity: Q2 2020 in Review
34 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2020, worth a combined $43.1M — up 19% from $36.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of RCEL and 10 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 11 added.
The largest buyer was Old Mission Capital, adding an estimated $7.25M. The largest seller was Blackcrane Capital, cutting an estimated $3.41M.
- 34 institutional investors held Avita Medical (RCEL) as of Q2 2020, down from 36 in Q1 2020.
- Funds reported $43.1M of Avita Medical stock for Q2 2020, up 19% quarter-over-quarter.
- 10 funds opened new Avita Medical positions in Q2 2020 and 12 closed out, a net change of -2 holders.
- The largest Avita Medical buyer in Q2 2020 was Old Mission Capital, an estimated $7.25M added.
- The largest Avita Medical seller in Q2 2020 was Blackcrane Capital, an estimated $3.41M sold.
Based on aggregated 13F filings for Q2 2020.